Literature DB >> 1908311

T cell-mediated inhibition of erythropoiesis in aplastic anaemia: the possible role of IFN-gamma and TNF-alpha.

A Miura1, K Endo, T Sugawara, J Kameoka, N Watanabe, K Meguro, O Fukuhara, I Sato, C Suzuki, K Yoshinaga.   

Abstract

The inhibitory activity of T cells on autologous erythroid colony-forming units (CFU-E) (T cell inhibitory activity) in patients with aplastic anaemia (AA) was investigated. In 11 (32.4%) out of 34 AA cases, T cell inhibition on autologous CFU-E growth was greater than that in normal individuals. In order to evaluate the mechanism of this inhibitory activity, T cell surface markers, interferon (IFN) production in peripheral blood mononuclear cell (PBMNC) liquid culture, and cytokine levels such as IFN and tumour necrosis factor-alpha (TNF-alpha) in CFU-E clot cocultured with T cells, were measured in a portion of the patients. In five patients investigated for IFN production in PBMNC liquid culture, all produced statistically more IFN activity than normal individuals under phytohaemagglutinin (PHA-P) stimulation (P less than 0.01) with no relation to T cell inhibitory activity. In only one patient whose T cells displayed increased CD8 and HLA-DR antigen (CD8+HLA-DR+) and inhibitory activity, a significant amount of IFN-gamma was observed in CFU-E clot cocultured with T cells, and the addition of anti-IFN-gamma antibody to the coculture resulted in recovered CFU-E colony growth. These results suggest that IFN-gamma production by T cells may explain, at least in part, the pathogenesis of haematopoietic defects in AA. In other patients however, T cell inhibitory activity neither correlated to the T cell subpopulations (CD4+/CD8+, CD8+HLA-DR+), IFN production in PBMNC liquid culture, nor to IFN and TNF-alpha levels in CFU-E clot culture. The roles played by cytokines other than IFN and TNF-alpha on haematopoietic precursor cells require further evaluation in a larger sample of patients with AA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908311     DOI: 10.1111/j.1365-2141.1991.tb04462.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapy.

Authors:  U Mentzel; H Vogt; R Rossol; R G Geissler; A Maurer; A Ganser; W E Trommer; D Hoelzer
Journal:  Ann Hematol       Date:  1993-03       Impact factor: 3.673

2.  Cytokine serum levels during treatment with high-dose recombinant human IL-3 in a patient with severe aplastic anemia.

Authors:  D Nachbaur; A Gratwohl; M Herold; A Tichelli; M Slanicka; C Nissen; D Niederwieser; B Speck
Journal:  Ann Hematol       Date:  1993-02       Impact factor: 3.673

Review 3.  Genetic associations in acquired immune-mediated bone marrow failure syndromes: insights in aplastic anemia and chronic idiopathic neutropenia.

Authors:  Irene Mavroudi; Helen A Papadaki
Journal:  Clin Dev Immunol       Date:  2012-08-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.